Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amarjit S Arneja

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Canadian Journal of Cardiology|April 1, 2004
Role of cholesterol in cardiovascular dysfunctionHarjot K Saini, Amarjit S Arneja, Naranjan S Dhalla
Experimental and Clinical Cardiology|April 4, 2009
The potential health benefits of taurine in cardiovascular diseaseYan-Jun Xu, Amarjit S Arneja, Paramjit S Tappia, et al.
Future Science OA|December 30, 2016
Electromagnetic fields in the treatment of chronic lower back pain in patients with degenerative disc diseaseAmarjit S Arneja, Alan Kotowich, Doug Staley, et al.
Expert Opinion on Therapeutic Targets|November 21, 2007
Targeting platelets for prevention and treatment of cardiovascular diseaseTodd A Duhamel, Yan-Jun Xu, Amarjit S Arneja, et al.
American Journal of Physical Medicine & Rehabilitation|March 19, 2015
Functional outcomes of patients with amputation receiving chronic dialysis for end-stage renal diseaseAmarjit S Arneja, Javaneh Tamiji, Brett M Hiebert, et al.
Canadian Journal of Physiology and Pharmacology|September 25, 2004
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockadeKanu R Shah, Pallab K Ganguly, Thomas Netticadan, et al.
Experimental and Clinical Cardiology|July 31, 2009
Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseasesMing Zhang, Yan-Jun Xu, Shushma A Mengi, et al.
Experimental and Clinical Cardiology|August 1, 2009
Pathogenesis of atherosclerosis: A multifactorial processRaja B Singh, Sushma A Mengi, Yan-Jun Xu, et al.
Journal of Cardiovascular Pharmacology|February 27, 2003
Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cellsYan-Jun Xu, Satyajeet S Rathi, Donald C Chapman, et al.
Journal of Cellular and Molecular Medicine|December 21, 2005
Pharmacological basis of different targets for the treatment of atherosclerosisHarjot K Saini, Yan-Jun Xu, Amarjit S Arneja, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Canadian Journal of Cardiology|April 1, 2004
Role of cholesterol in cardiovascular dysfunctionHarjot K Saini, Amarjit S Arneja, Naranjan S Dhalla
Experimental and Clinical Cardiology|April 4, 2009
The potential health benefits of taurine in cardiovascular diseaseYan-Jun Xu, Amarjit S Arneja, Paramjit S Tappia, et al.
Future Science OA|December 30, 2016
Electromagnetic fields in the treatment of chronic lower back pain in patients with degenerative disc diseaseAmarjit S Arneja, Alan Kotowich, Doug Staley, et al.
Expert Opinion on Therapeutic Targets|November 21, 2007
Targeting platelets for prevention and treatment of cardiovascular diseaseTodd A Duhamel, Yan-Jun Xu, Amarjit S Arneja, et al.
American Journal of Physical Medicine & Rehabilitation|March 19, 2015
Functional outcomes of patients with amputation receiving chronic dialysis for end-stage renal diseaseAmarjit S Arneja, Javaneh Tamiji, Brett M Hiebert, et al.
Canadian Journal of Physiology and Pharmacology|September 25, 2004
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockadeKanu R Shah, Pallab K Ganguly, Thomas Netticadan, et al.
Experimental and Clinical Cardiology|July 31, 2009
Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseasesMing Zhang, Yan-Jun Xu, Shushma A Mengi, et al.
Experimental and Clinical Cardiology|August 1, 2009
Pathogenesis of atherosclerosis: A multifactorial processRaja B Singh, Sushma A Mengi, Yan-Jun Xu, et al.
Journal of Cardiovascular Pharmacology|February 27, 2003
Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cellsYan-Jun Xu, Satyajeet S Rathi, Donald C Chapman, et al.
Journal of Cellular and Molecular Medicine|December 21, 2005
Pharmacological basis of different targets for the treatment of atherosclerosisHarjot K Saini, Yan-Jun Xu, Amarjit S Arneja, et al.
Pageof 2